Yaru Lu
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Plasma GFAP modifies the association of depressive symptoms with cognitive function: A population-based study.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: April 13, 2026
NOTCH3 Mutations in CADASIL Alter Lipid Metabolism: Insights from Patient Plasma and In Vitro Models.
Journal: Neurochemical research
Published: March 27, 2026
Simvastatin Ameliorates Lipid Metabolism-Mediated Endothelial Inflammation and Tight Junction Impairment in Chronic Cerebral Hypoperfusion.
Journal: Neuromolecular medicine
Published: November 06, 2025
Dl-3-n-Butylphthalide Alleviates Cognitive Impairment in Chronic Cerebral Hypoperfusion: Associations with Mitochondrial Permeability Transition Pore Closure and Suppression of Excessive Mitophagy.
Journal: ACS chemical neuroscience
Published: May 29, 2025
CD19+CD11c+T-bet+ B cells in myasthenia gravis: a potential biomarker.
Journal: Frontiers in neurology
Published: May 05, 2025
Mechanistic advances in factors influencing phenotypic variability in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a review.
Journal: Frontiers in neurology
Published: February 10, 2025
Mutant NOTCH3ECD Triggers Defects in Mitochondrial Function and Mitophagy in CADASIL Cell Models.
Journal: Journal of Alzheimer's disease : JAD
Published: July 20, 2024
Circulating CD45RA-Foxp3++ Treg cells serve as a biomarker for predicting minimal clinical manifestations status of myasthenia gravis.
Journal: Life sciences
Published: April 01, 2024
Analysis of the pathogenicity and pathological characteristics of NOTCH3 gene-sparing cysteine mutations in vitro and in vivo models.
Journal: Frontiers in molecular neuroscience
Published: February 26, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026